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Abstract
Background
Lymphatic filariasis (LF) and podoconiosis are neglected tropical diseases (NTDs) that pose
a significant physical, social and economic burden to endemic communities. Patients
affected by the clinical conditions of LF (lymphoedema and hydrocoele) and podoconiosis
(lymphoedema) need access to morbidity management and disability prevention (MMDP)
services. Clear estimates of the number and location of these patients are essential to the
efficient and equitable implementation of MMDP services for both diseases.
Methodology/Principle findings
A community-based cross-sectional study was conducted in Ethiopia using the Health
Extension Worker (HEW) network to identify all cases of lymphoedema and hydrocoele in
20 woredas (districts) co-endemic for LF and podoconiosis. A total of 612 trained HEWs and
40 supervisors from 20 districts identified 26,123 cases of clinical morbidity. Of these,
24,908 (95.3%) reported cases had leg lymphoedema only, 751 (2.9%) had hydrocoele,
387 (1.5%) had both leg lymphoedema and hydrocoele, and 77 (0.3%) cases had breast
lymphoedema. Of those reporting leg lymphoedema, 89.3% reported bilateral lymphoe-
dema. Older age groups were more likely to have a severe stage of disease, have bilateral
lymphoedema and to have experienced an acute attack in the last six months.
Conclusions/Significance
This study represents the first community-wide, integrated clinical case mapping of both LF
and podoconiosis in Ethiopia. It highlights the high number of cases, particularly of leg
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lymphoedema that could be attributed to either of these diseases. This key clinical informa-
tion will assist and guide the allocation of resources to where they are needed most.
Author summary
Patients affected by the clinical conditions of lymphatic filariasis (lymphoedema and
hydrocoele) and podoconiosis (lymphoedema) require access to a minimum package of
care to prevent progression of the disease, and to improve their quality of life. Clear esti-
mates of the number and location of these patients is essential for the delivery of this care.
To address this, a community-based cross-sectional study was conducted in Ethiopia
using the Health Extension Worker (HEW) network to identify all cases of lymphoedema
and hydrocoele in 20 co-endemic woredas (districts). A total of 26,123 cases of clinical
morbidity were identified. Of these, 24,908 (95.3%) had leg lymphoedema, of which
89.3% were bilateral. The results of this study will help assist the Neglected Tropical Dis-
ease (NTD) programme at the Federal Ministry of Health (FMOH) in Ethiopia to effec-
tively and equitably plan the delivery of a basic package of care to those suffering from the
clinical manifestations of both diseases.
Introduction
Lymphatic filariasis (LF) and podoconiosis are neglected tropical diseases (NTDs) that affect
the world’s poorest people and pose a significant economic burden to developing countries
[1]. Responsible for 90% of cases worldwide, Wuchereria bancrofti is the causative agent of LF
in Africa, and is transmitted through the bite of an infected mosquito. Infection with W. ban-
crofti can be either asymptomatic, or present as both acute and chronic clinical conditions.
However, the main clinical conditions of LF disease that are recognised as significant public
health priorities include acute dermatolymphangioadenitis (commonly known as acute
attacks), lymphoedema and hydrocoele [2]. More than 36 million people worldwide are
thought to be disfigured and incapacitated by this disease, leaving them vulnerable to an
extremely complex range of physical, social and economic hardships [3, 4].
Podoconiosis, unlike LF, is not due to an infectious agent but rather is the result of specific
inflammatory reactions to irritant mineral particles acquired from red clay soils derived from
volcanic deposits [5–7]. Specifically, greater quantities of smectite, mica and quartz within the
soil have been shown to have positive associations with podoconiosis prevalence [8]. It is
found in highland tropical areas of Africa, Central America and north-west India where there
is commonly a high seasonal rainfall [5, 6]. It is often termed “non-filarial” lymphoedema, and
can be generally clinically distinguished from LF lymphoedema by its ascending progression
of disease (rather than descending), and by being most commonly bilateral, as compared with
LF which is most commonly descending and unilateral [7, 9]. As with LF, stigmatisation is a
common and serious problem for those affected by podoconiosis, with patients experiencing
suicidal thoughts, dissolution of marriage plans, often receiving insults and being excluded at
social events [10]. Further, the economic consequences of the limb condition are profound,
with productivity losses per patient amounting to 45% of working days per year, causing a
monetary loss equivalent to US$ 63 per annum [11].
The World Health Assembly (WHA) adopted Resolution 50.29 in 1997, encouraging Mem-
ber States to eliminate LF as a public health problem [12]. Soon after, the World Health
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Organisation (WHO) launched the Global Programme to Eliminate LF (GPELF) with a target
date for achieving elimination by 2020. The two component strategies of GPELF are to a)
interrupt transmission through mass drug administration (MDA), and b) to manage morbid-
ity and prevent disability (MMDP) among those affected by the clinical manifestations of the
disease. Although no global target has yet been set for the elimination of podoconiosis [7],
strategies aimed at its control can be divided into primary, secondary and tertiary interven-
tions. Primary intervention includes the use of footwear, regular foot hygiene and the applica-
tion of floor coverings to reduce the contact between feet and the irritant soil. Secondary and
tertiary interventions focus on the management of the lymphoedema-related morbidity and
include wound care, exercise, elevation of the legs, treatment of acute attacks and providing
psychosocial and socio-economic support to those affected [7].
As the minimum package of care for managing the lymphoedema seen in LF and podoco-
niosis patients to manage morbidity is very similar, it is practical that MMDP should be inte-
grated to help improve cost-effectiveness and extend the reach of the programme [2]. This is
particularly important in Ethiopia where there is a high burden of both diseases, with 29 of the
70 LF-endemic districts considered to be co-endemic [13, 14]. However, before MMDP activi-
ties for both diseases can be implemented, better patient estimates and an understanding of
the co-distributions of both diseases at district level are vital. To assist the NTD programme at
the Federal Ministry of Health (FMOH) to effectively and equitably plan the delivery of a basic
package of care to those suffering from clinical manifestations of both diseases, we have exam-




Ethical approval for this study was obtained from the Research Ethics Committee at the Liver-
pool School of Tropical Medicine, UK (Research Protocol 12.22), and the Amhara and SNNP
Regional Health Bureaus in Ethiopia. Informed consent was obtained from all household
heads and patients involved in the study. All adult participants provided informed consent, no
children participated in the study. Participants who could read and write provided written
consent. Those who could not read and write, had the consent information read to them and
oral consent was recorded. The methods of collecting oral and written consent was approved
by the Regional Health Bureau ethical committees.
Study site characteristics
The study was conducted in the Southern Nations, Nationalities, and Peoples’ region
(SNNPR) and Amhara region of Ethiopia (Fig 1) between May and August 2015. In total 20
districts were selected; 14 districts from eight zones in the SNNPR, and six districts from three
zones in Amhara region, which had a total population of 3,075,318 (50.2% male) [15, 16].
At the time of the study, the 20 districts were considered to be co-endemic for LF and podo-
coniosis, with LF prevalence based on mapping conducted using immunochromatographic
card tests (ICT; Alere, Scarborough, ME, USA) to detect the presence of circulating W. ban-
crofti antigen as per the WHO protocol [17–19]. However, due to borderline endemicity in
districts, which had exactly the 1% prevalence threshold for endemicity, a subsequent ‘re-map-
ping’ validation was undertaken in nine of these 20 districts before the scale-up of MDA [14].
These nine districts were: Bensa, Saula Town (Sawla), Kebena, South Ari (Debub Ari), Guanga
(Guangua), Ebinat, Fogera, Simada (Semada) and E/Enawga (Inarj-Inawuga). This ‘re-map-
ping’ resulted in seven of these districts being reclassified as non-endemic, while two (South
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Ari and Simada), have remained endemic. The name and distribution of the non-endemic and
endemic districts are shown in S1 Fig [14]. With regards to the clinical burden of disease, prior
to the present study, no comprehensive information was available on the number of clinical
cases in these districts, and no available service provision for MMDP of lymphoedema and
hydrocoele. Before 2015, LF MDA had been initiated in only two of the 20 districts, Bero dis-
trict and Guraferda district of the Bench Maji zone. This MDA was integrated with the oncho-
cerciasis control programme.
Study design and tools
The community-based cross-sectional study was conducted using the Health Extension
Worker (HEW) network to identify cases. HEWs are predominately female, and are recruited
from the communities they serve to expand access to basic health promotion, disease preven-
tion and selected curative health services [20]. The HEWs searched for patients affected by LF
and podoconiosis in their community catchment areas, with two HEWs covering a population
of approximately 5,000 people [20]. Generally, two HEWs are assigned to cover one kebele.
The HEWs used a patient information collection form (translated into Amharic) to record
personal details including general demographic information (sex, age, occupation, rural/urban
residence, education level), and the condition of the patient (leg lymphoedema only, breast
lymphoedema, hydrocoele or ‘both’ leg lymphoedema and hydrocoele), and whether leg lym-
phoedema was unilateral or bilateral. Patients were also asked whether they had suffered an
acute attack in the past six months because of their swelling or lymphoedema.
Fig 1. Study regions in Ethiopia, and the number and prevalence per 10,000 of lymphoedema and hydrocoele cases by district. A. Lymphoedema–all cases. B.
Lymphoedema–all prevalence. C. Lymphoedema–bilateral cases. D. Lymphoedema–bilateral prevalence. E. Lymphoedema–unilateral cases. F. Lymphoedema–
unilateral prevalence. G. Hydrocoele–all cases. H. Hydrocoele–all prevalence. Note. The names of each district and their endemicity classification are shown in
reference S1 Fig.
https://doi.org/10.1371/journal.pntd.0006491.g001
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The severity of leg lymphoedema was staged as mild, moderate or severe using WHO rec-
ommended guidelines [21]. Patients with mild lymphoedema were categorised as those with a
slight, soft swelling; whilst moderate lymphoedema was an enlarged swelling with shallow
folds; and severe lymphoedema being greatly enlarged, with deep folds, and skin changes
including mossy lesions and nodules. HEWs were given an image of the three stages of lym-
phoedema to assist them in recording the staging. Due to the sensitivity of the condition,
HEWs were not asked to stage or confirm the presence of the hydrocoele, but just asked to
record the men reporting scrotal swelling. HEWs were not asked to differentiate between the
causes of lymphoedema (podoconiosis or lymphatic filariasis) as currently podoconiosis is a
diagnosis of clinical exclusion based on history, physical examination and certain disease-spe-
cific tests to exclude common differential diagnoses [18]. The use of such a complex clinical
algorithm, previously used in epidemiological mapping of LF and podoconiosis in Ethiopia
[18] was considered inappropriate for community-based health worker patient searching.
Training
In each district, all HEWs and two supervisors attended a one-day training session. The train-
ing focused on: a) how to identify lymphoedema and hydrocoele; b) how to classify lymphoe-
dema into the three stages; and c) how to record the patient information on the collection
form. In addition, all attendees were trained on morbidity management (basic care package)
for LF and podoconiosis to enable HEWs to give advice at the time of identification regarding
basic lymphoedema management, or to refer any suspected hydrocoele cases to their nearest
health facility for validation and further referral for surgery.
Data collection and analysis
Following the training, each HEW returned to her respective catchment area to identify all
cases of lymphoedema and hydrocoele through house-to-house patient searching; with the
two supervisors overseeing the data collection and acting as a point of contact if any problems
were encountered. The two HEWs assigned to each kebele as per the standard government
health system, were assigned to identify patients in the households they usually serve. For each
kebele, the HEWs used the list of households available in each kebele to prevent overlap
between the HEWs and to ensure all households were covered. During the data collection,
each HEW wrote the name of each household head on the data collection form, and this was
cross-checked against the list of households by the trained supervisors. To ensure no house-
holds were missed, HEWs sought support from the Health Development Army (volunteer
community health promoters) and the kebele administrative team to inform each specific
household of the date and time the HEW would visit the household for the patient searching.
The supervisors also visited a selection of the households to ensure they had been visited by
the HEWs.
The assessment was completed within ten days in most of the districts, with the data collec-
tion forms collated soon afterwards. All data was entered into Microsoft Excel Version 12.3.6
(Microsoft Corp., Redmond, VA, USA) and analysed using IBM SPSS Statistics 32 (IBM
Corp., Armonk, NY, USA). Prevalence estimates (per total 10,000 population) were calculated
using the 2015 population estimates as the denominator, which were calculated from the 2007
census [15] using the annual growth rates [16].
Statistical analysis between regions and variables including condition, severity of lymphoe-
dema, acute attacks, sex and age were examined using Pearson’s chi square with p value<0.05,
and/or odds ratios (OR) with 95% confidence intervals (95%CIs) to determine levels of signifi-
cance. Maps highlighting the study regions, and the number and prevalence of cases with
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lymphoedema and hydrocoele per 10,000 of the total population were produced using geo-
graphical information system (GIS) software ArcGIS 10 (ESRI., Redlands, CA, USA). Further
overall, lymphoedema and hydrocoele prevalence rates were compared between the newly
classified non-endemic districts and the endemic districts. In addition, to account for the dif-
ferent geographical sizes of the districts and to better understand the density of conditions, the
number of cases per square kilometre (km2) was calculated and presented in a supplementary
file (S1 Table).
Results
Summary of reported cases
A total of 612 HEWs and 40 supervisors from 20 districts were trained to collect and report
case data. Table 1 presents the number of cases reported per clinical condition for each region,
zone and district. A total of 26,123 cases (48% male; mean age 43.6 years) were reported. For
the SNNPR, the total was 17,285 cases (44.6% male; mean age 51.2 years) and for Amhara
region was 8,838 cases (54.8% male; mean age 43.8 years). Overall, the majority of cases were
Table 1. Reported number and prevalence (per 10,000 of the total population) of clinical cases.








N Prevalence N Prevalence N Prevalence N Prevalence N Prevalence
SNNPR Siliti 1 Lanfuro 142,581 1,781 124.9 20 1.4 3 0.2 1 0.1 1,805 126.6
2 Sankura 104,051 1,130 108.6 23 2.2 17 1.6 0 0.0 1,170 112.4
Sidama 3 Hawela Tula 152,844 405 26.5 4 0.3 1 0.1 0 0.0 410 26.8
4 Bensa ǂ 307,878 1,882 61.1 54 1.8 29 0.9 2 0.1 1,967 63.9
Gedeo 5 Yirga Chefe 239,763 1,699 70.9 57 2.4 13 0.5 0 0.0 1,769 73.8
Wollaita 6 Sodo zuria 199,775 2,564 128.3 12 0.6 5 0.3 0 0.0 2,581 129.2
GamoGofa 7 Boreda 83,451 1,078 129.2 14 1.7 6 0.7 25 3.0 1,123 134.6
8 Gezegofa 84,298 1,343 159.3 11 1.3 32 3.8 2 0.2 1,388 164.7
9 Oyida 40,903 624 152.6 7 1.7 18 4.4 0 0.0 649 158.7
10 Saula Town ǂ 27,879 247 88.6 1 0.4 0 0.0 0 0.0 248 89.0
Gurage 11 Kebena ǂ 64,318 892 138.7 29 4.5 10 1.6 0 0.0 931 144.7
Bench Maji 12 Bero 15,050 105 69.8 0 0.0 0 0.0 0 0.0 105 69.8
13 Guraferda 43,311 663 153.1 12 2.8 4 0.9 0 0.0 679 156.8
South Omo 14 South Ari 258,552 2,277 88.1 41 1.6 101 3.9 42 1.6 2,461 95.2
SNNP regional total 1,764,654 16,690 94.6 284 1.6 239 1.4 72 0.4 17,285 98.0
Amhara Awi 15 Zigem 82,174 1,203 146.4 34 4.1 23 2.8 2 0.2 1,262 153.6
16 Guanga ǂ 191,738 1,487 77.6 38 2.0 54 2.8 3 0.2 1,582 82.5
South Gondor 17 Ebinat ǂ 270,365 1,080 39.9 112 4.1 6 0.2 0 0.0 1,198 44.3
18 Fogera ǂ 280,522 1,932 68.9 72 2.6 31 1.1 0 0.0 2,035 72.5
19 Simada 280,304 1,033 36.9 157 5.6 10 0.4 0 0.0 1,200 42.8
East Gojam 20 E/Enawga ǂ 205,560 1,483 72.1 53 2.6 24 1.2 0 0.0 1,560 75.9
Amhara regional total 1,310,663 8,218 62.7 467 3.6 148 1.1 5 0.04 8,838 67.4
Overall total 3,075,318 24,908 81.0 751 2.4 387 1.3 77 0.3 26,123 84.9
 Hydrocoele prevalence based on total population
 Both refers to patients identified as having both hydrocoele and lymphoedema conditions
ǂ Remapping indicated that these districts were non-endemic [14]
https://doi.org/10.1371/journal.pntd.0006491.t001
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either subsistence farmers (n = 17,243; 66%) or housewives (n = 5,557; 21.3%), had perma-
nently lived in the rural setting (n = 24,198; 92.6%), had not attended school and were illiterate
(n = 21,631; 82.8%)
In terms of clinical conditions, the total number of cases reported comprised of 24,908
(95.3%) leg lymphoedema, 751 (2.9%) hydrocoele, 387 (1.5%) both leg lymphoedema and
hydrocoele, and 77 (0.3%) breast lymphoedema. No individual patient was reported as having
both a breast lymphoedema and a leg lymphoedema, and from this point onwards, the term
‘both conditions’ refers to a patient having both a leg lymphoedema and a hydrocoele. The
maps shown in Fig 1A–1H highlight the case and prevalence distributions across the study
area. The districts with the highest number of cases were Sodo Zuria district, Wollaita zone
(n = 2,581), and South Ari district, South Omo zone (n = 2,461) of the SNNPR (Table 1). The
districts with the lowest number of cases were Bero district, Bench Maji zone (n = 105), and
Saula Town, GamoGofa zone (n = 248) of the SNNPR. The distribution of all cases by district
is shown in Fig 1A.
Overall, the morbidity prevalence rate was 84.9 per 10,000 total population (Table 1). The
SNNPR rate of 98.0 per 10,000 was significantly higher than the Amhara region rate of 67.4
per 10,000 (OR 1.46; 95%CIs 1.42–1.50; P< 0.0001). The districts with the highest prevalence
rates were Gezegofa district (164.7 per 10,000), and Oyida district (158.7 per 10,000) in the
GamoGofa zone of the SNNPR, while the district with the lowest was Hawela Tula district,
Sidama zone (26.8 per 10,000) of the SNNPR. The distribution of all cases is shown in Fig 1B.
When comparing by endemicity status, the overall prevalence rate in the non-endemic dis-
tricts of 70.6 per 10,000 was significantly lower than the endemic districts (96.1 per 10,000)
(OR 0.73; CIs 0.71–0.75; P<0.0001).
The density of cases overall was 17.53 cases per km2 (see S1 Table). The SNNPR (23.60
cases per km2) had a higher density of cases than the Amhara region (11.66 cases per km2).
The highest district level density of cases were in the urban areas, Saula Town, GamoGofa
zone (634.85 per km2) of the SNNPR, and Zigem, Awi zone (467.11 per km2) of the Amhara
region. The lowest density of cases were in Bero district (2.18 cases per km2), and Guraferda
district (3.35 cases per km2) of the Bench Maji zone of the SNNPR.
Lymphoedema cases
Summary. Overall, leg lymphoedema (only) accounted for most of the cases reported and
was found in similar patterns to the total number of cases and prevalence rates described
above and shown in Table 1. The districts with the highest number of cases were Sodo zuria
district, Wollaita zone (n = 2,564), and the lowest was Bero district, Bench Maji zone (n = 105)
of the SNNPR. Similarly, the overall lymphoedema prevalence rate was 81.0 per 10,000 total
population. The SNNPR rate of 94.6 per 10,000 was significantly higher than the Amhara
region rate of 62.7 per 10,000 (OR 1.51; 95%CIs 1.47–1.55; P< 0.0001). The district with the
highest prevalence rate was Gezegofa district, GamoGofa zone (159.3 per 10,000), and the low-
est was Hawela Tula district, Sidama zone (26.5 per 10,000) of the SNNPR. When comparing
by endemicity status, the lymphoedema prevalence rate in the non-endemic districts (66.8 per
10,000) was significantly lower than the endemic districts (92.1 per 10,000) (OR 0.73; CIs
0.71–0.74; P<0.0001). In addition, similar trends in the density of lymphoedema cases was
found as the overall total as shown in S1 Table.
Overall, more females (54.2%; n = 13,495) reported leg lymphoedema (only) than males.
The majority of cases were aged above 30 years of age, with similar patterns for both males and
females. The distribution of leg lymphoedema by age and sex is shown in Fig 2A. A small num-
ber of male cases reported having both a leg lymphoedema and a hydrocoele (n = 387) in 18 of
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the 20 districts. A smaller number of females reported having breast lymphoedema (n = 77) in
7 of the 20 districts, with most recorded in South Ari district, South Omo zone (n = 42) and
Boreda district, GamaGofa zone (n = 25) of the SNNPR (Table 1). The distribution of breast
lymphoedema and hydrocoele cases by age and sex is shown in Fig 2B.
Number of limbs affected by leg lymphoedema. In total, 25,295 cases reported leg
lymphoedema, including those with leg lymphoedema (only), and those with both leg lym-
phoedema and hydrocoele. Of these, 89.3% (n = 22,597) reported they had bilateral leg lym-
phoedema with similar percentages found in both the SNNPR (89.9%) and Amhara region
(88.1%). More variation at district level was reported with the percentage of bilateral leg lym-
phoedema cases ranging from 80.2% to 96.1%. The number and distribution of unilateral and
bilateral cases by district are summarised in Table 2 and shown in Fig 1A, 1C and 1E.
The overall ratio of unilateral to bilateral leg lymphoedema cases was 1:8, which was similar
between the SNNPR (1:9) and Amhara region (1:7). Similarly, there was more variation at dis-
trict level with ratios ranging from 1:4 to 1:24, with the highest reported in Hawela Tula dis-
trict, Sidama zone (1:24) and Yirga Chefe district, Gedeo zone (1:21) and the lowest in Bensa
district, Sidama zone of the SNNPR (1:4).
Similarly, the overall prevalence of unilateral (8.8 per 10,000) and bilateral (73.5 per 10,000)
lymphoedema cases differed, with similar large differences between unilateral and bilateral
leg lymphoedema within each region. When comparing regions, a significantly higher preva-
lence of unilateral lymphoedema was reported in the SNNPR (9.6 per 10,000) compared with
Amhara region (7.6 per 10,000) (OR 1.27; CIs 1.17–1.37; P<0.0001). Similarly, a significantly
higher prevalence of bilateral lymphoedema was reported in the SNNPR (86.3 per 10,000)
compared with Amhara region (56.2 per 10,000) (OR 1.54; CIs 1.50–1.58; P<0.0001). The
overall prevalence and distribution of all, unilateral and bilateral cases are summarised in
Table 2 and shown in Fig 1B, 1D and 1F.
Severity of leg lymphoedema. The number of cases (n = 25,295) reporting mild, moder-
ate or severe leg lymphoedema (including those with leg lymphoedema only and both leg lym-
phoedema and hydrocoele) varied significantly (chi square<0.05). Over half of the cases were
recorded as mild (57.8%; n = 14,492), approximately one third as moderate (33.8%; n = 8,538)
and 9% as severe (n = 2,265). The proportion of male and female cases for each stage was simi-
lar, with just over half of mild, moderate and severe cases being female; 54.1%, 52.6% and
51.6%, respectively.
Fig 2. Number of leg lymphoedema, breast lymphoedema and hydrocoele cases by sex and age. A. Leg lymphoedema. B. Breast lymphoedema and hydrocele.
https://doi.org/10.1371/journal.pntd.0006491.g002
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In terms of age, significant differences were found in the mean age and the different stages
of leg lymphoedema, with an increasing trend in the severity of the condition by age group.
The mean age of cases reporting mild, moderate and severe leg lymphoedema was 45.1 years
(95% CI 44.8–45.3), 47.6 years (95% CI 47.3–47.9) and 49.0 years (95% CI 48.3–49.6)
respectively.
Hydrocoele cases
In all 20 districts, the total number and prevalence of men reporting hydrocoele was low with
only 751 cases reported overall and a prevalence of 2.4 per 10,000 population (Table 1). The
SNNPR rates of 1.6 per 10,000 was significantly lower than the Amhara region rates of 3.6 per
10,000 (OR 0.45; 95%CIs 0.39–0.52; p< 0.0001). The two districts with the highest number of
cases and prevalence rates were Simada district (n = 157; 5.6 per 10,000), and Ebinat district
(n = 112; 4.1 per 10,000), South Gondor zone in Amhara region. Of note, Ebinat district was
recently re-classified as ‘non-endemic’ for LF [14]. Bero district, Bench Maji zone in the
SNNPR reported no cases. All reported cases of hydrocoele were male with the majority aged
41 to 60 years (41.9%; n = 315) The number of cases reported increased with age as highlighted
in Fig 2B. When comparing by endemicity status, the hydrocoele prevalence rate in the non-
Table 2. Reported number, prevalence (per 10,000 of the total population) and ratio of unilateral and bilateral cases of leg lymphoedema.
Region Zone District Total population Leg lymphoedema Bilateral % of total Unilateral: bilateral ratio (n)
Unilateral Bilateral Total
N Prevalence N Prevalence
SNNPR Siliti Lanfuro 142,581 186 13.0 1,598 112.1 1,784 89.6% 1: 9
Sankura 104,051 116 11.1 1,031 99.1 1,147 89.9% 1: 9
Sidama Hawela Tula 152,844 16 1.0 390 25.5 406 96.1% 1: 24
Bensa ǂ 307,878 379 12.3 1,532 49.8 1,911 80.2% 1: 4
Gedeo Yirga Chefe 239,763 77 3.2 1,635 68.2 1,712 95.5% 1: 21
Wollaita Sodo zuria 199,775 245 12.3 2,324 116.3 2,569 90.5% 1: 9
GamoGofa Boreda 83,451 123 14.7 961 115.2 1,084 88.7% 1: 8
Gezegofa 84,298 93 11.0 1,282 152.1 1,375 93.2% 1: 14
Oyida 40,903 54 13.2 588 143.8 642 91.6% 1: 11
Saula Town ǂ 27,879 13 4.7 234 83.9 247 94.7% 1: 18
Gurage Kebena ǂ 64,318 138 21.5 764 118.8 902 84.7% 1: 6
Bench Maji Bero 15,050 9 6.0 96 63.8 105 91.4% 1: 11
Guraferda 43,311 60 13.9 607 140.1 667 91.0% 1: 10
South Omo South Ari 258,552 193 7.5 2,185 84.5 2,378 91.9% 1: 11
SNNP regional total 1,764,654 1,702 9.6 15,227 86.3 16,929 89.9% 1: 9
Amhara Awi Zigem 82,174 113 13.8 1,113 135.4 1,226 90.8% 1: 10
Guanga ǂ 191,738 81 4.2 1,460 76.1 1,541 94.7% 1: 18
South Gondor Ebinat ǂ 270,365 190 7.0 896 33.1 1,086 82.5% 1: 5
Fogera ǂ 280,522 212 7.6 1,751 62.4 1,963 89.2% 1: 8
Simada 280,304 184 6.6 859 30.6 1,043 82.4% 1: 5
East Gojam E/Enawga ǂ 205,560 216 10.5 1,291 62.8 1,507 85.7% 1: 6
Amhara regional total 1,310,663 996 7.6 7,370 56.2 8,366 88.1% 1: 7
Overall total 3,075,318 2,698 8.8 22,597 73.5 25,295 89.3% 1: 8
Leg lymphoedema including those with leg lymphoedema only and both conditions (lymphoedema and hydrocoele)
ǂ Remapping indicated that these districts were non-endemic [14]
https://doi.org/10.1371/journal.pntd.0006491.t002
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endemic districts of 2.7 per 10,000 was significantly higher than the endemic districts of 2.3
per 10,000 (OR 1.2; CIs 1.0–1.4; P = 0.029).
The density of hydrocoele cases overall was very low at 0.5 cases per km2 (see S1 Table).
The SNNPR (0.39 cases per km2) had a lower density of cases than the Amhara region (0.62
cases per km2). The highest district level density of cases were in the urban areas, Saula Town,
GamoGofa zone (2.56 cases per km2) of the SNNPR, and Zigem, Awi zone (12.58 cases per
km2) of the Amhara region. The lowest density of cases was in Guraferda district (0.06 cases
per km2), Bench Maji zone of the SNNPR.
Acute attacks
Of all the 26,123 cases identified, a total of 1,931 cases did not record any reliable information
on acute attacks in the last six months, and therefore were excluded from this analysis
(Table 3). Of the 24,192 cases with information recorded, approximately two-thirds (64.1%;
n = 15,517/24,192) reported that they had at least one acute attack in the last six months due to
their swelling/lymphoedema. Similar proportions were recorded for those with leg lymphoe-
dema (64.5%; n = 14,935/23,165), and/or both conditions (65.3%; n = 211/323). Men with
hydrocoele (54.5%; n = 343/629) and women with breast lymphoedema (37.3%; n = 28/75)
reported fewer acute attacks.
Overall, a higher percentage of females reported they had an acute attack in the last six
months (65.7%; n = 8,305/12,642) than males (62.4%; n = 7,212/11,550), this was a significant
difference (OR 1.13; 95%CIs 1.07–1.19) (Table 3). Overall, the percentage of acute attacks
increased with age, which was similar for both males and females (Fig 3A). The lowest percent-
age of acute attacks reported were in the<20 year age group (56.4%) and the highest in the
older >60 year age group (69.9%). A significantly higher percentage of females reported acute
attacks than males across all age groups; an exception to this was the>60 year age group as
shown in Table 3.
Table 3. Reported acute attacks for all conditions by different age groups and by sex.
Overall Differences by sex
Age group Total cases No. Positive (%) Sex Subtotal (n) Total positive Positive % Age–sex OR (95% CI) P value
<20 974 549 (56.4%) M 368 185 50.3% 1.49 (1.15–1.93) 0.0029
F 606 364 60.1%
20–29 1,969 1,155 (58.7%) M 756 416 55.0% 1.27 (1.06–1.53) 0.0098
F 1,213 739 60.9%
30–39 4,803 2,911 (60.6%) M 2,068 1,199 58.0% 1.21 (1.07–1.36) 0.0012
F 2,735 1,712 62.6%
40–49 5,865 3,723 (63.5%) M 2,732 1,668 61.1% 1.21 (1.09–1.35) 0.0003
F 3,133 2,055 65.6%
50–59 4,921 3,220 (65.4%) M 2,318 1,459 62.9% 1.23 (1.09–1.39) 0.0005
F 2,603 1,761 67.7%
>60 5,660 3,959 (69.9%) M 3,308 2,285 69.1% 1.11 (0.98–1.24) 0.0898
F 2,352 1,674 71.2%
Total 24,192 15,517 (64.1%) M 11,550 7,212 62.4% 1.13 (1.07–1.19) <0.0001
F 12,642 8,305 65.7%
A total of 1,931 participants did not record information on acute attacks and therefore were excluded from the analysis. In the table, positive refers to patients who
reported experiencing at least one acute attack in the last six months.
 Statistically significant at <0.05
https://doi.org/10.1371/journal.pntd.0006491.t003
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In terms of severity of leg lymphoedema, a total of 23,488 cases had information recorded
(Table 4). Overall, the percentage of acute attacks reported increased with the severity of the
condition; mild (62.8%; n = 8,529), moderate (65.2%; n = 5,111) and severe (72.5%; n = 1,506)
as shown in Fig 3B. A significantly higher percentage of females reported acute attacks with
mild (OR 1.17; 95%CIs 1.10–1.26) and moderate (OR 1.12; 95%CIs 1.02–1.23) conditions than
males, however no difference by sex was found with severe conditions.
Discussion
This study represents the first community-wide integrated clinical case survey of both LF
and podoconiosis in Ethiopia. In the 2007 epidemiological mapping of LF in 112 districts of
Western Ethiopia, only advanced cases of LF-related lymphoedema and hydrocoele were
reported from selected villages within the surveyed districts [17]. Later, during the integrated
Fig 3. Proportion of cases experiencing acute attacks by age group and severity of lymphoedema stratified by sex. A. Age group. B. Severity of lymphoedema.
https://doi.org/10.1371/journal.pntd.0006491.g003
Table 4. Reported leg lymphoedema severity and acute attacks of reported cases.
Severity Overall Differences by sex
Total cases No. positive (%) Sex Subtotal (n) Total positive Positive % OR (95% CI) P value
Mild 13,577 8,529 (62.8%) M 6223 3780 60.7% 1.17 (1.10–1.26) <0.0001
F 7354 4749 64.6%
Moderate 7,833 5,111 (65.2%) M 3698 2361 63.8% 1.12 (1.02–1.23) 0.0136
F 4135 2750 66.5%
Severe 2,078 1,506 (72.5%) M 1000 728 72.8% 0.97 (0.80–1.17) 0.748
F 1078 778 72.2%
Total 23,488 15,146 (64.5%) M 10921 6869 62.9% 1.14 (1.08–1.20) <0.0001
F 12567 8277 65.9%
Leg lymphoedema included those cases reporting leg lymphoedema only and both conditions. In total 1,807 cases of 25,295 total number were excluded from the
analysis as they did not record information on acute attacks. In the table, positive refers to patients who reported experiencing at least one acute attack in the last six
months.
 Statistically significant at <0.05
https://doi.org/10.1371/journal.pntd.0006491.t004
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endemicity mapping in 658 districts in 2013, clinical cases of LF and podoconiosis had only
been reported from two kebeles per district using a two-stage cluster purposive sampling strat-
egy [18, 19]. Other studies assessing the clinical burden of either LF or podoconiosis individu-
ally have generally only been conducted at a smaller geographical scale, and only in districts
known to be endemic for the specific disease [22–27].
The present survey results highlight a greater burden of lymphoedema cases compared to
that of hydrocoele, with over 33 times as many leg lymphoedema cases reported than hydro-
coele. These results differ to other studies on clinical case estimates in African LF-endemic
countries including Malawi and Tanzania where the number of hydrocoele cases identified
was almost double that of lymphoedema cases identified [28, 29].This is likely to be related to
the presence of podoconiosis in Ethiopia. Here we highlight that the vast majority of lymphoe-
dema cases were bilateral; a manifestation more typically seen with non-filarial lymphoedema
[9]. Although these results suggest that a clear majority of lymphoedema cases identified are
likely to be caused by podoconiosis rather than filariasis, this present study did not distinguish
between the causes of lymphoedema. These results are supported by previous findings by
Deribe et al [30], which highlights the huge burden of podoconiosis in the SNNP and Amhara
regions of Ethiopia, particularly in the central highland area where distinct environmental and
climatic factors are suitable for podoconiosis occurrence. LF tests including circulating filarial
antigen testing, filarial antibody examination and parasitological examination have been used
to exclude an LF diagnosis in other studies in LF and podoconiosis co-endemic areas [31], but
for the purposes of understanding the burden of lymphoedema to establish MMDP interven-
tions in this study, a detailed understanding of aetiology was not required as the same MMDP
interventions are required for both filarial and non-filarial lymphoedema.
Regardless of aetiology, the high number of leg lymphoedema cases highlights the pressing
need to deliver a basic package of care to those suffering from these disabling conditions, espe-
cially in areas with a high prevalence and/or high density of conditions where patients may be
more readily found and the distribution of care easier. The delivery of a low-cost lymphoe-
dema management programme based on limb washing and topical medication for infection
has been shown to reduce the number of debilitating acute attacks and to increase the eco-
nomic productivity of patients [32]. An integrated MMDP programme will help the majority
of lymphoedema cases in these districts as most were identified as having a mild severity and
are likely to respond well to such treatment [33]. Such an MMDP programme should be fully
integrated into the existing health system structure to ensure sustainability and to help achieve
universal health coverage. It should also promote early detection of mild lymphoedema cases,
which may be underreported by HEWs, to prevent progression to a more severe stage of
lymphoedema.
A verification exercise to confirm reported cases of lymphoedema and hydrocoele by a cli-
nician has been used in other studies to validate the reporting method used for patient search-
ing [28, 29] but due to financial and time constraints, was not included in this study. Such
verification exercises have evidenced that community health workers are exceptionally well-
placed to participate in quantifying LF morbidity burden, and other NTDs with observable
symptoms [29], such as podoconiosis. As other countries begin to develop their own methods
for obtaining patient estimates to achieve the second component of the GPELF strategy, this
study has highlighted that integrated patient searching using community health workers is an
effective strategy. By including two diseases, this method is cost-effective and empowers local
health workers to contribute to local, national and global elimination of disease.
In this study, those with more severe disease were shown to be more likely to have experi-
enced an acute attack in the past six months. This is not a surprising result as the presence of
moisture, which commonly accumulates in swollen folds of skin, or the web spaces of toes
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during lymphoedema promotes fungal infections, leading to an acute attack [34–36]. Also,
older age groups were shown to have a more severe stage of disease, were more likely to have
bilateral lymphoedema, and were more likely to have experienced an acute attack in the past
six months. As lymphoedema is a chronic, progressive condition, this is to be anticipated and
highlights the important need to implement an accessible package of care to all lymphoedema
patients to prevent the progression of their condition to a more disabling and debilitating
severe stage.
The low number of hydrocoele cases identified in this study further suggests that LF is of
low prevalence in these regions of Ethiopia, and that with well-targeted morbidity strategies,
GPELF targets could be reached. However, it is important to consider that as hydrocoele is a
highly stigmatised condition [37], the numbers reported in this study could be an underesti-
mation. As HEWs are predominately female and likely to be from the same community as the
patient [20], some patients may not have disclosed their condition to their HEW. For those
hydrocoele cases identified in this study and those that may remain hidden, it is important to
identify equitable ways to refer and facilitate access to safe hydrocoele surgery to repair their
condition. In an effort to support this, international partners have worked together with the
Federal Ministry of Health (FMOH) in Ethiopia to develop a hydrocoele surgical handbook
and trained regional surgeons across Ethiopia on surgical best practise [38]. Such surgery has
been shown to positively impact patients’ lives, improving their physical and socio-economic
output [39] and to be highly cost-effective [40]. Facilitating access to surgery in the districts
now classified as ‘non-endemic’ will be particularly important as patients could miss out on
treatment if resources are not prioritised to these districts, especially as the prevalence rates
were higher than the endemic districts. However, it will still remain important to provide
services for lymphoedema patients in these regions also, whether they are caused by LF or
podoconiosis.
In order to achieve the second pillar of the GPELF plan, services to alleviate the suffering of
clinical disease needs to be available within primary health care systems in all areas of known
patients [41]. The results of this study highlight the profound burden of clinical disease, partic-
ularly lymphoedema. Since 2015, funds have been mobilised by the Centre for Neglected Trop-
ical Diseases at the Liverpool School of Tropical Medicine (LSTM) with funding from the
Department for International Development (UKAID) to provide lymphoedema and hydro-
coele patients across all 20 districts with access to care. The results of this study have therefore
helped to improve the management of both LF and podoconiosis morbidity, and will assist the
NTD programme in Ethiopia to achieve elimination goals.
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